Antidepressant ‘shrooms: rebranding psilocybin as medication [W[R]C]

https://www.biotechniques.com/neuroscience/antidepressant-shrooms-rebranding-psilocybin-as-medication/

Sixtine Fleury is a second-year graduate student in the Nautiyal Lab at Dartmouth College (NH, USA). At this year’s meeting of the Society for Neuroscience (SfN; 12–16 November; San Diego, CA, USA), she presented a poster on altered consciousness and the role of the non-hallucinatory serotonin 1B receptor in psilocybin’s therapeutic effects.

We had the chance to chat to her about her poster and her experience at SfN.

Become a supporter of this podcast: https://www.spreaker.com/podcast/world-reading-club-w-r-c--5667160/support.